Sunrest Lifescience

Sunrest Lifescience Net Tangible Assets

The Net Tangible Assets of Sunrest Lifescience (SUNREST.NS) as of Nov 1, 2026 is 163.03 M INR. In the previous year, Net Tangible Assets was 141.79 M INR — a change of 14.98% (higher).

Net Tangible Assets

163.03 MINR

YoY

14.98%

Last updated:

Net Tangible Assets of Sunrest Lifescience is 2025 163.03 M INR. Net Tangible Assets of Sunrest Lifescience was 2024 141.79 M INR. It decreases by 14.98% higher compared to the previous year.

The Sunrest Lifescience Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2021
2.90 M INR
Jan 1, 2022
10.70 M INR
Jan 1, 2023
31.20 M INR
Jan 1, 2024
141.79 M INR
Jan 1, 2025
163.03 M INR
The Sunrest Lifescience Net Tangible Assets history
YEARNet Tangible AssetsYoY
163.03 MINR+14.98%
141.79 MINR+354.44%
31.20 MINR+191.59%
10.70 MINR+268.97%
2.90 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sunrest Lifescience Stock analysis

What does Sunrest Lifescience do? Sunrest Lifescience Ltd markets OTC generic pharmaceutical products manufactured by third party manufacturers. The company sells capsules, tablets, syrup, ointment, gel, mouth wash, solution, suspension, dry powders, and toothpaste. Its product portfolio includes Anti-Bacterial, Anti Diarrheal, Antifungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory drugs. The company operates in Maharashtra, Gujarat, Madhya Pradesh, Orissa, and Rajasthan, selling to stockists who distribute products to chemist shops, dispensaries, and hospitals. Sunrest Lifescience Ltd targets domestic markets through third party manufacturers for OTC generic products. The firm's sales channels include stockists who supply chemist shops, dispensaries, and hospitals across multiple Indian states. The company's product range serves various health segments from anti-bacterial treatments to multivitamins and dental care. The company's revenue comes from the sale of OTC generic pharmaceutical products to stockists, who then distribute them to end consumers via chemist shops, dispensaries, and hospitals. Sunrest Lifescience Ltd focuses on domestic market distribution without direct retail presence, leveraging third party manufacturers for product supply. Sunrest Lifescience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunrest Lifescience stock

Net Tangible Assets of Sunrest Lifescience is 163.03 M INR in 2025.

Net Tangible Assets of Sunrest Lifescience changed from 141.79 M INR to 163.03 M INR, representing a 14.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets Sunrest Lifescience since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's Sunrest Lifescience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sunrest Lifescience

All Key Metrics — Sunrest Lifescience